Foghorn Therapeutics Inc. - Common Stock — Statistiche Finanziarie Trimestrali (NASDAQ:FHTX) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -24.52 M-23.97 M-21 M-18.86 M-22.27 M-25.27 M -87.4 M Flussi di cassa derivanti dalle attività di investimento 22.29 M29.4 M33.83 M35.57 M13.23 M-17.72 M 64.92 M Liquidità derivante dalle attività di finanziamento 4 000139 K254 K49 K581 K49.77 M 50.66 M Liquidità libera -24.52 M-23.97 M-21.02 M-18.86 M-22.27 M-25.27 M -87.42 M

Notizie

CorMedix (CRMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Lags Revenue Estimates

Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Top Estimates

Foghorn Therapeutics Inc. (FHTX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Tops Revenue Estimates

Stifel conferma il rating su Foghorn Therapeutics dopo i dati AACR

H.C. Wainwright conferma il rating buy su Foghorn Therapeutics

Foghorn presenta dati preclinici per candidati farmaci antitumorali

Foghorn presenta dati preclinici sul cancro al meeting AACR

Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?

Citizens conferma il rating su Foghorn Therapeutics per i progressi della pipeline

Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress